Spyre Therapeutics
SYRE
#5620
Rank
โ‚น79.73 B
Marketcap
โ‚น1,323
Share price
1.27%
Change (1 day)
-53.76%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of โ‚น73.75 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 N/A-100%
2023 โ‚น73.75 M-61.73%
2022 โ‚น0.19 B-86.18%
2021 โ‚น1.39 B
2020 N/A
2019 N/A-100%
2018 โ‚น0.27 B-18.18%
2017 โ‚น0.33 B5.66%
2016 โ‚น0.31 B-22.23%
2015 โ‚น0.40 B
2014 N/A